Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Surely they share the same tech company and they have made a simple mistake. That is all it will be?
I think its because IL6 and IFN are both parts of the immune system - production of one modulates the other.
IL6 might be influenced by inhaled IFN.
SNG has demostrated the principle of modifying the system by inhalation of these products. Will they compete?
My interpretation is IL6 will target sicker patients - as such high price but lower volume.
A third drug related to IL1 is produved by Swedish Orphan. Its in trials now. I am in all three.
I wondered about that too. Would be amazing if it does and we've another iron in the fire.
So why is Syairgen mentioned on TILS website? does our inhaler Patent that covers Remdisivir cover the way Synairgen SNG001 is inhaled? if so wow!
Hey yes you are not going mad lol !
Didn't the good Doctor Shaliu found synairgen originally ? I seem to remember reading somewhere he had something to do with Synairgen in the past ???
very strange do they have the same web company and someone copied and pasted the wrong thing?
Robert. Exact same statement on SNG website.
https://www.synairgen.com/
https://ir.tizianalifesciences.com/presentation
The Tiziana link above does indeed say SNG001?
whys it talking about sng001 on tils website?
My understanding having invested in SNG was that SNG001 was the SNG COVID trial “
sng001 from www.pharmatimes.com
20 Jul 2020 · Southampton, UK-based Synairgen has announced positive results from a clinical trial of SNG001, its wholly-owned inhaled ...”
I am confused!!!
Are you on the wrong board ;)
this is on their website:
shorturl.at/pzOV3
Investor Presentations
TLSA Investor Presentation August 2020
A replay of the webinar hosted 20 July 2020 discussing positive results of SNG001 in hospitalised COVID-19 patients is available here.
isnt that synairgen?!?